— Know what they know.
Not Investment Advice

LVVV OTC

LiveWire Ergogenics, Inc.
1W: +0.0% 1M: -25.0% 3M: -25.0% YTD: -50.0% 1Y: -0.0% 3Y: -91.3% 5Y: -98.5%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±12.5%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $571194 mcap · 19M float · 3.79% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$2M -71.6% ▼
5Y CAGR: -4.9%
Total Liabilities
$4M -19.7% ▼
5Y CAGR: -1.1%
Shareholders Equity
-$2M -146.7% ▼
Cash & Investments
$1K -86.9% ▼
5Y CAGR: -57.8%
Total Debt
$3M -9.0% ▼
5Y CAGR: -1.1%
Net Debt
$3M -8.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$200K$76K$28K$11K$1K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$200K$76K$28K$11K$1K
Net Receivables$4M$6M$7M$7M$242K
Inventory$2K$0$0$0$0
Other Current Assets$31K$0$0$0$0
Total Current Assets$4M$6M$7M$8M$244K
Property, Plant & Equip.$361K$234K$196K$184K$165K
Goodwill & Intangibles$5K$0$0$0$0
Long-Term Investments$269K$269K$269K$269K$2M
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$636K$503K$465K$453K$2M
Total Assets$5M$6M$8M$8M$2M
— Liabilities —
Accounts Payable$760K$1M$1M$1M$86K
Short-Term Debt$3M$3M$3M$3M$3M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$640K
Total Current Liabilities$4M$4M$5M$5M$4M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$4M$4M$5M$5M$4M
— Equity —
Common Stock$174K$183K$186K$190K$190K
Retained Earnings-$28M-$28M-$27M-$27M-$31M
Accumulated OCI$351K$402K$428K$428K$428K
Total Stockholders Equity$912K$2M$3M$3M-$2M
Total Liabilities & Equity$5M$6M$8M$8M$2M
— Key Metrics —
Total Debt$3M$3M$3M$3M$3M
Net Debt$3M$3M$3M$3M$3M
Total Investments$269K$269K$269K$269K$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms